Skip Header

 
Contribute Send feedback
Read comments (1) or add your own

Reviewed, UniProtKB/Swiss-Prot P78324 (SHPS1_HUMAN)

Last modified June 16, 2009. Version 101. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (7) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Tyrosine-protein phosphatase non-receptor type substrate 1
      Short name=SHP substrate 1
      Short name=SHPS-1
Alternative name(s):
    Inhibitory receptor SHPS-1
    Signal-regulatory protein alpha-1
      Short name=Sirp-alpha-1
    Sirp-alpha-2
    Sirp-alpha-3
    MyD-1 antigen
    Brain Ig-like molecule with tyrosine-based activation motifs
      Short name=Bit
    Macrophage fusion receptor
    p84
    CD172 antigen-like family member A
    CD_antigen=CD172a
Gene names
Name: SIRPA
Synonyms: BIT, MFR, MYD1, PTPNS1, SHPS1, SIRP
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length503 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Immunoglobulin-like cell surface receptor for CD47. Acts as docking protein and induces translocation of PTPN6, PTPN11 and other binding partners from the cytosol to the plasma membrane. Supports adhesion of cerebellar neurons, neurite outgrowth and glial cell attachment. May play a key role in intracellular signaling during synaptogenesis and in synaptic function By similarity. Involved in the negative regulation of receptor tyrosine kinase-coupled cellular responses induced by cell adhesion, growth factors or insulin. Mediates negative regulation of phagocytosis, mast cell activation and dendritic cell activation. CD47 binding prevents maturation of immature dendritic cells and inhibits cytokine production by mature dendritic cells.

Subunit structure

Binds PTPN11 when tyrosine-phosphorylated, except in macrophages, where it primarily binds PTPN6. Binds GRB2 in vitro. Binds FGR By similarity. Binds JAK2 irrespective of its phosphorylation status and forms a stable complex. Binds SCAP1 and/or SCAP2. The resulting complex recruits FYB. Binds PTK2B.

Subcellular location

Membrane; Single-pass type I membrane protein.

Tissue specificity

Ubiquitous. Highly expressed in brain. Detected on myeloid cells, but not T-cells. Detected at lower levels in heart, placenta, lung, testis, ovary, colon, liver, small intestine, prostate, spleen, kidney, skeletal muscle and pancreas.

Post-translational modification

N-glycosylated. Ref.2 Ref.11

Phosphorylated on tyrosine residues in response to stimulation with EGF, growth hormone, insulin and PDGF. Dephosphorylated by PTPN11. Ref.2 Ref.9

Sequence similarities

Contains 2 Ig-like C1-type (immunoglobulin-like) domains.

Contains 1 Ig-like V-type (immunoglobulin-like) domain.

Ontologies

Keywords
   Cellular componentMembrane
   Coding sequence diversityAlternative splicing
Polymorphism
   DomainImmunoglobulin domain
Repeat
SH3-binding
Signal
Transmembrane
   PTMDisulfide bond
Glycoprotein
Phosphoprotein
   Technical term3D-structure
Gene Ontology (GO)
   Biological processcell adhesion Ref.1

Traceable author statement. Source: ProtInc

   Cellular componentintegral to membrane

Inferred from electronic annotation. Source: UniProtKB-KW

plasma membrane Ref.1

Inferred from Experiment. Source: Reactome

   Molecular functionSH3 domain binding

Inferred from electronic annotation. Source: UniProtKB-KW

Complete GO annotation...

Alternative products

This entry describes 3 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: P78324-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: P78324-2)

The sequence of this isoform differs from the canonical sequence as follows:
     421-421: Q → QVQSL
Note: No experimental confirmation available.
Isoform 3 (identifier: P78324-3)

The sequence of this isoform differs from the canonical sequence as follows:
     1-101: Missing.
Note: No experimental confirmation available.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Signal peptide1 – 3030 Potential
Chain31 – 503473Tyrosine-protein phosphatase non-receptor type substrate 1
PRO_0000014941

Regions

Topological domain27 – 372346Extracellular Potential
Transmembrane373 – 39321 Potential
Topological domain394 – 503110Cytoplasmic Potential
Domain32 – 137106Ig-like V-type
Domain147 – 246100Ig-like C1-type 1
Domain253 – 34795Ig-like C1-type 2
Motif428 – 4314SH2-binding Potential
Motif438 – 4436SH3-binding Potential
Motif452 – 4554SH2-binding Potential
Motif469 – 4724SH2-binding Potential
Motif495 – 4984SH2-binding Potential

Amino acid modifications

Modified residue4281Phosphotyrosine; by Tyr-kinases Potential
Modified residue4521Phosphotyrosine; by Tyr-kinases Potential
Modified residue4691Phosphotyrosine; by Tyr-kinases By similarity
Modified residue4951Phosphotyrosine; by Tyr-kinases By similarity
Glycosylation2441N-linked (GlcNAc...) Ref.11
Glycosylation2691N-linked (GlcNAc...)
Glycosylation2911N-linked (GlcNAc...)
Glycosylation3181N-linked (GlcNAc...) Potential
Disulfide bond55 ↔ 121 Ref.13 Ref.14
Disulfide bond169 ↔ 227 Potential
Disulfide bond272 ↔ 330 Potential

Natural variations

Alternative sequence1 – 101101Missing in isoform 3.
VSP_007029
Alternative sequence4211Q → QVQSL in isoform 2.
VSP_007030
Natural variant6 – 72PA → RS
VAR_015462
Natural variant201A → P
VAR_015463
Natural variant401D → E
VAR_015464
Natural variant441S → L Ref.4 Ref.6 Ref.7
VAR_015465
Natural variant501S → T Ref.4 Ref.6 Ref.7
VAR_015466
Natural variant521I → A Requires 2 nucleotide substitutions. Ref.4 Ref.6 Ref.7
VAR_015467
Natural variant521I → T Ref.4 Ref.6 Ref.7
VAR_015468
Natural variant541H → E Requires 2 nucleotide substitutions. Ref.4 Ref.6 Ref.7
VAR_015469
Natural variant541H → R Ref.4 Ref.6 Ref.7
VAR_015470
Natural variant571V → A Ref.4 Ref.6 Ref.7
VAR_015471
Natural variant611I → N
VAR_015472
Natural variant681W → R
VAR_015473
Natural variant751A → G: dbSNP rs1057114. Ref.4 Ref.6 Ref.7
VAR_015474
Natural variant771E → K
VAR_015475
Natural variant811N → H
VAR_015477
Natural variant951E → D Ref.4 Ref.6 Ref.7 Ref.3
VAR_015478
Natural variant961S → L Ref.4 Ref.6 Ref.7 Ref.3
VAR_015479
Natural variant1001E → N Requires 2 nucleotide substitutions. Ref.4 Ref.6 Ref.7 Ref.3
VAR_015480
Natural variant1001E → T Requires 2 nucleotide substitutions. Ref.4 Ref.6 Ref.7 Ref.3
VAR_015481
Natural variant1071S → C Ref.4 Ref.6 Ref.7 Ref.3
VAR_015482
Natural variant1071S → R Ref.4 Ref.6 Ref.7 Ref.3
VAR_015483
Natural variant1091S → G Ref.4 Ref.6 Ref.7 Ref.3
VAR_015484
Natural variant1251R → Q
VAR_015485
Natural variant1311T → V Requires 2 nucleotide substitutions. Ref.4 Ref.6 Ref.7 Ref.3
VAR_015486
Natural variant1331F → L
VAR_015487
Natural variant1621Q → D Requires 2 nucleotide substitutions.
VAR_015488
Natural variant1801T → S
VAR_015489
Natural variant1891E → Q
VAR_015490
Natural variant200 – 2012VG → AR
VAR_015491
Natural variant2131K → N
VAR_015492
Natural variant2191E → G
VAR_015493
Natural variant2211V → I
VAR_015494
Natural variant2351Q → R
VAR_015495
Natural variant238 – 2392PL → SF
VAR_015496
Natural variant2501R → Q
VAR_015497
Natural variant2601Q → L
VAR_015498
Natural variant2621V → M
VAR_015499
Natural variant2701V → I
VAR_015500
Natural variant2751R → T
VAR_015501
Natural variant3011V → L: dbSNP rs2422666.
VAR_015502
Natural variant3381P → S
VAR_015503
Natural variant3521P → L
VAR_015504
Natural variant3561G → S
VAR_015505
Natural variant3661S → P
VAR_015506
Natural variant3691R → Q
VAR_015507
Natural variant3881A → E
VAR_015508
Natural variant4421Q → R
VAR_015509
Natural variant4591P → L
VAR_015510
Natural variant4851A → L Requires 2 nucleotide substitutions.
VAR_015511
Natural variant4901P → L
VAR_015512

Experimental info

Sequence conflict1301D → DD in CAA71944. Ref.3
Sequence conflict1301D → DD in BAA87929. Ref.4
Sequence conflict1301D → DD in CAC12723. Ref.6
Sequence conflict1301D → DD in CAB38874. Ref.6
Sequence conflict1301D → DD in AAH33092. Ref.7
Sequence conflict2581T → I in CAA71944. Ref.3
Sequence conflict4181E → K in AAF19260. Ref.6
Sequence conflict4841P → L in AAF19260. Ref.6
Sequence conflict4981V → I in AAF19260. Ref.6
Sequence conflict5021R → K in CAA71944. Ref.3

Secondary structure

......................... 503
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 [UniParc].

Last modified May 1, 1997. Version 1.
Checksum: E9C5477363180512

FASTA50354,813
        10         20         30         40         50         60 
MEPAGPAPGR LGPLLCLLLA ASCAWSGVAG EEELQVIQPD KSVSVAAGES AILHCTVTSL 

        70         80         90        100        110        120 
IPVGPIQWFR GAGPARELIY NQKEGHFPRV TTVSESTKRE NMDFSISISN ITPADAGTYY 

       130        140        150        160        170        180 
CVKFRKGSPD TEFKSGAGTE LSVRAKPSAP VVSGPAARAT PQHTVSFTCE SHGFSPRDIT 

       190        200        210        220        230        240 
LKWFKNGNEL SDFQTNVDPV GESVSYSIHS TAKVVLTRED VHSQVICEVA HVTLQGDPLR 

       250        260        270        280        290        300 
GTANLSETIR VPPTLEVTQQ PVRAENQVNV TCQVRKFYPQ RLQLTWLENG NVSRTETAST 

       310        320        330        340        350        360 
VTENKDGTYN WMSWLLVNVS AHRDDVKLTC QVEHDGQPAV SKSHDLKVSA HPKEQGSNTA 

       370        380        390        400        410        420 
AENTGSNERN IYIVVGVVCT LLVALLMAAL YLVRIRQKKA QGSTSSTRLH EPEKNAREIT 

       430        440        450        460        470        480 
QDTNDITYAD LNLPKGKKPA PQAAEPNNHT EYASIQTSPQ PASEDTLTYA DLDMVHLNRT 

       490        500 
PKQPAPKPEP SFSEYASVQV PRK 

« Hide

Isoform 2.

Checksum: CDFDA403B6781E96
Show »

FASTA50755,240
Isoform 3.

Checksum: E4479F67E64D76F9
Show »

FASTA40244,165

References

« Hide 'large scale' references
[1]"Mouse and human SHPS-1: molecular cloning of cDNAs and chromosomal localization of genes."
Yamao T., Matozaki T., Amano K., Matsuda Y., Takahashi N., Ochi F., Fujioka Y., Kasuga M.
Biochem. Biophys. Res. Commun. 231:61-67(1997) [PubMed: 9070220] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
Tissue: Brain.
[2]"A family of proteins that inhibit signalling through tyrosine kinase receptors."
Kharitonenkov A., Chen Z., Sures I., Wang H., Schilling J., Ullrich A.
Nature 386:181-186(1997) [PubMed: 9062191] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), POLYMORPHISM, PHOSPHORYLATION, GLYCOSYLATION, INTERACTION WITH PTPN11; PTPN6 AND GRB2.
Tissue: Placenta.
[3]"Cloning of two members of the SIRP alpha family of protein tyrosine phosphatase binding proteins in cattle that are expressed on monocytes and a subpopulation of dendritic cells and which mediate binding to CD4 T cells."
Brooke G.P., Parsons K.R., Howard C.J.
Eur. J. Immunol. 28:1-11(1998) [PubMed: 9485180] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), VARIANTS ASP-95; LEU-96; ASN-100; ARG-107; GLY-109 AND VAL-131.
Tissue: Monocyte.
[4]"Gene structure of mouse BIT/SHPS-1."
Sano S., Ohnishi H., Kubota M.
Biochem. J. 344:667-675(1999) [PubMed: 10585853] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS LEU-44; THR-50; THR-52; ARG-54; ALA-57; GLY-75; ASP-95; LEU-96; ASN-100; ARG-107; GLY-109 AND VAL-131.
Tissue: Brain.
[5]"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. expand/collapse author list , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
[6]"The DNA sequence and comparative analysis of human chromosome 20."
Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P., Bird C.P., Blakey S.E. expand/collapse author list , Bridgeman A.M., Brown A.J., Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P., Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E., Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J., Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D., Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S., Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D., Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A., Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T., Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I., Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.
Nature 414:865-871(2001) [PubMed: 11780052] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANTS LEU-44; THR-50; THR-52; ARG-54; ALA-57; GLY-75; ASP-95; LEU-96; ASN-100; ARG-107; GLY-109 AND VAL-131.
[7]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), VARIANTS LEU-44; THR-50; THR-52; ARG-54; ALA-57; GLY-75; ASP-95; LEU-96; ASN-100; ARG-107; GLY-109 AND VAL-131.
Tissue: Brain, Kidney and Skin.
[8]"SHPS-1 is a scaffold for assembling distinct adhesion-regulated multi-protein complexes in macrophages."
Timms J.F., Swanson K.D., Marie-Cardine A., Raab M., Rudd C.E., Schraven B., Neel B.G.
Curr. Biol. 9:927-930(1999) [PubMed: 10469599] [Abstract]
Cited for: FUNCTION, INTERACTION WITH FYB; SCAP2 AND PTK2B.
[9]"Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha."
Stofega M.R., Argetsinger L.S., Wang H., Ullrich A., Carter-Su C.
J. Biol. Chem. 275:28222-28229(2000) [PubMed: 10842184] [Abstract]
Cited for: PHOSPHORYLATION BY JAK2, INTERACTION WITH PTPN11 AND JAK2.
[10]"Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation."
Latour S., Tanaka H., Demeure C., Mateo V., Rubio M., Brown E.J., Maliszewski C., Lindberg F.P., Oldenborg A., Ullrich A., Delespesse G., Sarfati M.
J. Immunol. 167:2547-2554(2001) [PubMed: 11509594] [Abstract]
Cited for: FUNCTION, INTERACTION WITH CD47.
[11]"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry."
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., Smith R.D.
J. Proteome Res. 4:2070-2080(2005) [PubMed: 16335952] [Abstract]
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-244, MASS SPECTROMETRY.
Tissue: Plasma.
[12]"Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.
J. Proteome Res. 8:651-661(2009) [PubMed: 19159218] [Abstract]
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-269 AND ASN-291, MASS SPECTROMETRY.
Tissue: Liver.
[13]"The structure of the macrophage signal regulatory protein alpha (SIRPalpha) inhibitory receptor reveals a binding face reminiscent of that used by T cell receptors."
Hatherley D., Harlos K., Dunlop D.C., Stuart D.I., Barclay A.N.
J. Biol. Chem. 282:14567-14575(2007) [PubMed: 17369261] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 31-148, DISULFIDE BOND.
[14]"Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47."
Hatherley D., Graham S.C., Turner J., Harlos K., Stuart D.I., Barclay A.N.
Mol. Cell 31:266-277(2008) [PubMed: 18657508] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 31-148 IN COMPLEX WITH CD47, DISULFIDE BOND.
+Additional computationally mapped references.

Cross-references

Sequence databases

D86043 mRNA. Translation: BAA12974.1.
Y10375 mRNA. Translation: CAA71403.1.
Y11047 mRNA. Translation: CAA71944.1. Different initiation.
AB023430 mRNA. Translation: BAA87929.1.
AK290776 mRNA. Translation: BAF83465.1.
AC004832 Genomic DNA. Translation: AAF19260.1.
AL034562 Genomic DNA. Translation: CAB38874.2.
AL117335 Genomic DNA. Translation: CAC12723.2.
BC026692 mRNA. Translation: AAH26692.1.
BC033092 mRNA. Translation: AAH33092.1.
BC038510 mRNA. Translation: AAH38510.1.
BC075849 mRNA. Translation: AAH75849.1.
IPIIPI00332887.
IPI00656087.
IPI00848309.
PIRJC5287.
RefSeqNP_001035111.1.
NP_001035112.1.
NP_542970.1.
UniGeneHs.581021
Hs.679042

3D structure databases

EntryMethodResolution (Å)ChainPositionsPDBsum
2JJSX-ray1.85A/B31-148[»]
2JJTX-ray2.30A/B31-148[»]
2UV3X-ray1.80A/B31-148[»]
ModBaseSearch...

Protein-protein interaction databases

IntActP78324. 3 interactions.

PTM databases

PhosphoSiteP78324.

Proteomic databases

PRIDEP78324.

Genome annotation databases

EnsemblENSG00000198053. Homo sapiens. [Contig view]
GeneID140885.
KEGGhsa:140885.

Organism-specific databases

GeneCardsGC20P001822.
H-InvDBHIX0041373.
HGNCHGNC:9662. SIRPA.
HPACAB002776.
CAB015122.
MIM602461. gene.
GenAtlasSearch...

Phylogenomic databases

HOVERGENP78324.

Enzyme and pathway databases

ReactomeREACT_604. Hemostasis.
REACT_6900. Signaling in Immune system.

Gene expression databases

ArrayExpressP78324.
BgeeP78324.
GermOnlineENSG00000198053. Homo sapiens.

Family and domain databases

InterProIPR007110. Ig-like.
IPR013783. Ig-like_fold.
IPR003597. Ig_C1-set.
IPR003599. Ig_sub.
IPR013106. Ig_V-set.
[Graphical view]
Gene3DG3DSA:2.60.40.10. Ig-like_fold. 3 hits.
PfamPF07654. C1-set. 2 hits.
PF07686. V-set. 1 hit.
[Graphical view]
SMARTSM00409. IG. 1 hit.
SM00407. IGc1. 2 hits.
[Graphical view]
PROSITEPS50835. IG_LIKE. 3 hits.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio84534.
SOURCESearch...

Entry information

Entry nameSHPS1_HUMAN
AccessionPrimary (citable) accession number: P78324
Secondary accession number(s): A8K411 expand/collapse secondary AC list , O00683, O43799, Q8N517, Q8TAL8, Q9H0Z2, Q9UDX2, Q9UIJ6, Q9Y4U9
Entry history
Integrated into UniProtKB/Swiss-Prot: March 28, 2003
Last sequence update: May 1, 1997
Last modified: June 16, 2009
This is version 101 of the entry and version 1 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)

Relevant documents

Human cell differentiation molecules

CD nomenclature of surface proteins of human leucocytes and list of entries

Human chromosome 20

Human chromosome 20: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents